Riboflavin and migraine: the bridge over troubled mitochondria

Area of Science:

• Neuroscience
• Metabolic disorders
• Mitochondrial function

Background:

• Brain energy metabolism is frequently disturbed in individuals experiencing migraines.
• Mitochondrial dysfunction may lower the migraine attack threshold, increasing neuronal excitability and brain hyper-responsiveness.
• This suggests a potential link between cellular energy deficits and migraine susceptibility.

Purpose of the Study:

• To investigate the role of riboflavin in addressing impaired brain energy metabolism in migraine.
• To evaluate the safety and efficacy of riboflavin as a prophylactic treatment for migraine.

Main Methods:

• Review of Randomized Controlled Trial (RCT) studies in adult populations.
• Analysis of evidence regarding riboflavin's impact on mitochondrial function and oxidative metabolism.
• Assessment of safety and probable effectiveness for migraine prophylaxis.

Main Results:

• Riboflavin is confirmed as safe for use in adult migraine patients.
• Evidence suggests riboflavin is probably effective in migraine prophylaxis (Level B evidence).
• Improving brain energy metabolism may reduce migraine susceptibility.

Conclusions:

• Mitochondrial defects contributing to disturbed brain energy metabolism are implicated in migraine pathophysiology.
• Riboflavin, as a crucial co-factor in oxidative metabolism, may counteract these impairments.
• Enhancing brain energy metabolism holds potential for reducing migraine susceptibility.